The cutaneous microbiota

Bacteria, funguses and viruses good for our skin

March 22, 2019 - external seminar of Gilles TRUAN

Protein engineering to optimize a synthetic metabolic pathway leading to β-carotene synthesis in S. cerevisiae

March 19, 2019 - external seminar of Professor and Dean Surajit SENGUPTA

Crystals, proteins and spatial patterning of colloidal particles: a low dimensional collective coordinate for deformation

Thesis

Kevin Moreau will support his thesis on 21 March 2019

March 15, 2019 - external seminar of Kyle PHUA

Host gene expression inhibition: a novel immune evasion property that facilitates mRNA translation and possibly much more

March 8, 2019 - external seminar of Dr Marc DHENAIN

Multimodal integrative imaging and therapy of Alzheimer's disease: From the imaging of amyloid plaques by MRI to 3D histopathology

Escape Game - Week of the brain - 11 to 15th of march 2019

During the week of the brain 2019, come and take part to an escape game which has been designed by researchers of the group "Cibles pharmacologiques et biomarqueurs" of the CBM and of the team "Neurotoxicité et développement" of the INEM laboratory !

seminar "Bees societies, human societies, an interdependence from prehistory to the future"

On january 24th and 25th, Jean-Marc BONMATIN co-organized this seminar at the CNRS headquarters in Paris, where the challenges fo sustainable beekeeping have been discussed.

A new interpretation of neutron scattering spectra

In an article in PNAS, Professor G. R. Kneller gives a new interpretation of neutron scattering spectra by molecular systems inspired by the Franck-Condon theory.

Cover page of a volume of the journal "Chemistry-A European Journal"

CBM researchers make the cover page of a volume of the journal "Chemistry-A European Journal" during a work dedicated to the creation and rationalization of the behavior of Erbium complexes, formed with a new generation of ligands, to generate the luminescence of Er which is rarely observed in the visible range for a molecular compound. The results of this work, carried out in close collaboration with researchers from the Chemistry Section of the University of Geneva in Switzerland, open up major new perspectives in the field of higher molecular energy converters.

CBM researchers have created the first method for detecting non-covalent complexes of biomolecules by MALDI mass spectrometry based on liquid deposits

So far, the standard approach for analyzing molecule complexes in native mass spectrometry, ie by keeping the complexes intact in the instrument, used electrospray to produce the ions to be detected. MALDI ionization, however, has many advantages, such as reduced sample consumption and better tolerance to certain additives or contaminants, and its use opens new perspectives in native mass spectrometry.

CBM researchers have worked out a new generation of metallacryptates

CBM researchers, in collaboration with the team of Professor Vincent L. Pecoraro of the University of Michigan in the United States, have created a new generation of metal cryptates incorporating cations with a very particular architecture. The compounds belonging to this family combine original magnetic properties of slow relaxation with luminescence properties in the visible and in the near-infrared.

CBM researchers involved in an effort to structure Nanomedicine research at European level.

Great meeting of the National Nanomedicine Platforms organized by NOBEL during ETPN2018, May 29, in Berlin.

The first computational method to predict Rho-dependent termination of transcription.

This method, based on multivariate statistical modeling of a large set of experimental data generated for the occasion, allows the prediction of potential sites of Rho-dependent transcription termination at the level of whole bacterial genomes.

MicroRNA-Based Drugs for Brain Tumors

MicroRNAs (miRNAs) are key regulatory elements encoded by the genome. A single miRNA can downregulate the expression of multiple genes involved in diverse functions. Because cancer is a disease with multiple gene aberrations, developing novel approaches to identify and modulate miRNA pathways may result in a breakthrough for cancer treatment. With a special focus on glioblastoma (GBM), this review provides an up-to-date summary of miRNA biogenesis, the role of miRNA in cancer resistance, and essential tools for modulating miRNA expression, as well as of clinically promising RNAi delivery systems and how they can be adapted for therapy.